Abstract
The author explains how the European Court of Justice (ECJ) ruling in the case of R v Medicines Control Agency ex parte Generics (Case C-368/96) elucidated the controversial meaning of the concept of essential similarity involved in the authorisation of medicinal products under EC legislation. Article by Dr Frank Wooldridge (University of Notre Dame, London) published in Amicus Curiae - Journal of the Institute of Advanced Legal Studies and its Society for Advanced Legal Studies. The Journal is produced by the Society for Advanced Legal Studies at the Institute of Advanced Legal Studies, University of London.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
